fda compounding semaglutide warning november 2025 crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many New project announcement: HHS‑OIG is

One in 8 American adults now takes a GLP-1 drug to manage diabetes or obesity

Do not change your dose without guidance from the prescribing clinician

The 8mg and 12mg doses of retatrutide produce faster, more dramatic weight loss

Women who have used Depo-Provera and subsequently been diagnosed with brain tumors are filing lawsuits against Pfizer (the manufacturer), alleging that the company failed to adequately warn about the risks associated with the drug

The company is enrolling 150 people with a BMI of 20 or higher who want to microdose for health and longevity with no intention of losing weight

'Ozempic Face' is a media term used to describe individuals who have lost a significant amount of weight using Ozempic, leading to a transformation from a round to a slimmer face